Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Invasive Breast Cancer × cemiplimab × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Head and Neck Neoplasms 5 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Invasive Breast Cancer 1 Hemangiosarcoma 1

Interventions

Paclitaxel 3 Doxorubicin 3 Cyclophosphamide 3 Trastuzumab 2 Surgical Procedures, Operative 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Radiotherapy 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1 Indocyanine Green 1 Anastrozole 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡